Trade Mark Journal No.2021/053 31 December 2021

WO0000001630185 (5)

Office of origin: United States of America

Date of International Registration:2 November 2021
Date of designation in the UK: 2 November 2021
Image for mark 1630185 EPRONTIA

International priority date claimed: 5 May 2021 (United States of America) (90690878)
Class 5
Pharmaceutical formulations and compositions containing topiramate; pharmaceutical preparations for the preventative treatment of seizures or migraines; anticonvulsants.

Azurity Pharmaceuticals, Inc.

Representative: Douglas R. Wolf Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA